Ronald Walls

Background

About Ronald Walls

I am a licensed US pharmaceutical physician(Surgical Oncologist) with 24 years of Global Clinical Development,Medical Affairs, Business Development and Pharmacovigilance expertise.I offer extensive Executive "hands-on and sleeves rolled up" leadership building global patient-centric and value-based teams Extensive leadership in clinical trial design (Phase 1-4), implementation/execution of protocols, use of adaptive design, biomarkers and digital endpoints to decrease time from lab to launch.Risk-based Medical Monitoring. Assumed leadership of 24-year old $1B+/year branded compound (declining market share because of heavy generic competition) and increased sales to $3.2B/year in 3 years with 2 successful sNDAs and 1NDA.Managed team of 50+ employees, rebuilding entire division from the ground up. Assumed Executive C-Suit Leadership of The CSPC Pharmaceutical Group for the Americas (China’s 3rd largest biopharma) and grew the company from 7 employees to 69 employees in less than 3 years. Lead one successful sNDA and FDA approval. Leading US Key Opinion Leader on Increasing Accrual (and Retention) of Racially Diverse Subjects and Physicians into Industry-Sponsored Clinical Research. FOUNDER - The Alliance of Minority Medical Associations Encompassing the Executive Councils of the National Medical Association, National Hispanic Medical Association, Association of American Indian and Alaskan Native Physicians. Built 5 patient-centristic & value-based global Medical Affairs Teams ( & Field-Based Medical Science Liaisons) from the ground up saving companies billions in vendor fees. Provide fluid and long-term Business Development, Clinical Development, Pharmacovigilance strategies to support investment decisions (go/no go) for healthcare/life sciences finance companies and offer them value-creation partnerships that maximize their ROI and generate significant business pull-through SPECIALTIES Medical Affairs, Government Affairs | Clinical Research & Development | Sales Training | Pharmaceutical Marketing | Key Opinion Leader/Patient Advocacy Group /Payer Relationship Cultivation | Due Diligence/Acquisitions/In-Licensing | Patient Centricity | Business Development THERAPEUTIC AREA: Oncology | Rare Diseases | Movement Disorders | Endocrinology | Urology | Cell Therapy | Gene Therapy | Neurodegenerative Disorders *Filed Two INDs, Six NDAs, Two BLAs, and Three NDA 505(b)(2) with the FDA of which Five are Successful Products on the Market Today*